Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2730-664X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit ; volume:3 ; number:1 ; day:7 ; month:2 ; year:2023 ; pages:1-14 ; date:12.2023
Communications medicine ; 3, Heft 1 (7.2.2023), 1-14, 12.2023

Classification: Medizin, Gesundheit

Creator: Tomlins, Scott A.
Khazanov, Nickolay A.
Bulen, Benjamin J.
Hovelson, Daniel H.
Shreve, Melissa J.
Lamb, Laura E.
Matrana, Marc R.
Burkard, Mark E.
Yang, Eddy Shih-Hsin
Edenfield, William Jeffery
Dees, E. Claire
Onitilo, Adedayo A.
Thompson, Michael
Buchschacher, Gary L.
Miller, Alan M.
Menter, Alexander
Parsons, Benjamin
Wassenaar, Timothy
Hwang, Leon C.
Suga, J. Marie
Siegel, Robert
Irvin, William
Nair, Suresh
Slim, Jennifer N.
Misleh, Jamal
Khatri, Jamil
Masters, Gregory
Thomas, Sachdev
Safa, Malek
Anderson, Daniel M.
Kwiatkowski, Kat
Mitchell, Khalis
Hu-Seliger, Tina
Drewery, Stephanie
Fischer, Andrew
Plouffe, Komal
Czuprenski, Eric
Hipp, Jennifer
Reeder, Travis
Vakil, Hana
Johnson, D. Bryan
Rhodes, Daniel R.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s43856-023-00243-7

URN: urn:nbn:de:101:1-2023042921095974043218

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tomlins, Scott A.
Khazanov, Nickolay A.
Bulen, Benjamin J.
Hovelson, Daniel H.
Shreve, Melissa J.
Lamb, Laura E.
Matrana, Marc R.
Burkard, Mark E.
Yang, Eddy Shih-Hsin
Edenfield, William Jeffery
Dees, E. Claire
Onitilo, Adedayo A.
Thompson, Michael
Buchschacher, Gary L.
Miller, Alan M.
Menter, Alexander
Parsons, Benjamin
Wassenaar, Timothy
Hwang, Leon C.
Suga, J. Marie
Siegel, Robert
Irvin, William
Nair, Suresh
Slim, Jennifer N.
Misleh, Jamal
Khatri, Jamil
Masters, Gregory
Thomas, Sachdev
Safa, Malek
Anderson, Daniel M.
Kwiatkowski, Kat
Mitchell, Khalis
Hu-Seliger, Tina
Drewery, Stephanie
Fischer, Andrew
Plouffe, Komal
Czuprenski, Eric
Hipp, Jennifer
Reeder, Travis
Vakil, Hana
Johnson, D. Bryan
Rhodes, Daniel R.
SpringerLink (Online service)

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1 binding studies using microscale thermophoresis

The PD-1:PD-L1 axis in Inflammatory Arthritis

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Related objects

Reset password